Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaojie Shi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Medicinal Chemistry|July 27, 2021
Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectivesLin Yue, Yaojie Shi, Xingping Su, et al.
Bioorganic Chemistry|August 14, 2021
Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4Wang Xiang, Qiwei Wang, Kai Ran, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
Pharmaceutical Research|April 20, 2026
Bio-inspired White Tablet Coating Film Without Titanium DioxideYutong Tian, Shihao Song, Yaojie Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2016
A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumorsHongxia Deng, Jun Zeng, Yongxia Zhu, et al.
European Journal of Medicinal Chemistry|November 23, 2021
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancerWei Wei, Zhanzhan Feng, Zhihao Liu, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancerHualong He, Wan Yang, Yaojie Shi, et al.
European Journal of Medicinal Chemistry|June 30, 2019
Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitisYaojie Shi, Qianqian Wang, Juan Rong, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2016
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agentsKai Ran, Chao Gao, Hongxia Deng, et al.
Scientific Reports|July 14, 2016
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChao Gao, Cuiting Peng, Yaojie Shi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|July 27, 2021
Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectivesLin Yue, Yaojie Shi, Xingping Su, et al.
Bioorganic Chemistry|August 14, 2021
Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4Wang Xiang, Qiwei Wang, Kai Ran, et al.
Journal of Medicinal Chemistry|March 20, 2023
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future PerspectivesYuting Xie, Lin Yue, Yaojie Shi, et al.
Pharmaceutical Research|April 20, 2026
Bio-inspired White Tablet Coating Film Without Titanium DioxideYutong Tian, Shihao Song, Yaojie Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2016
A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumorsHongxia Deng, Jun Zeng, Yongxia Zhu, et al.
European Journal of Medicinal Chemistry|November 23, 2021
Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancerWei Wei, Zhanzhan Feng, Zhihao Liu, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancerHualong He, Wan Yang, Yaojie Shi, et al.
European Journal of Medicinal Chemistry|June 30, 2019
Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitisYaojie Shi, Qianqian Wang, Juan Rong, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2016
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agentsKai Ran, Chao Gao, Hongxia Deng, et al.
Scientific Reports|July 14, 2016
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChao Gao, Cuiting Peng, Yaojie Shi, et al.
Pageof 2